Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | SRPT | MLYS | ||
| Company | Ra Pharmaceuticals Inc | Sarepta Therapeutics | Mineralys Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.99 | 21.92 | 28.01 | ||
| High | 48.01 | 22.66 | 29.09 | ||
| Low | 47.98 | 21.65 | 26.27 | ||
| Latest | 48.00 | 22.13 | 26.41 | ||
| Change | -0.02 | +0.37 | -0.68 | ||
| % Change | -0.03% | +1.70% | -2.51% | ||
| Volume | 3,864,600 | 2,074,500 | 1,069,800 | ||
| 20-Day Average Volume | 1,869,975 | 3,566,320 | 1,488,315 | ||
| Previous Close | 48.01 | 21.76 | 27.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 18.42 | 25.38 | ||
| 20-Day Raw Stochastic | 99.68% | 79.34% | 46.50% | ||
| 20-Day Relative Strength | 56.47 | 59.69 | 47.55 | ||
| Weighted Alpha | +21.70 | -6.91 | -3.43 | ||
| Today's Opinion | 56% Buy | 8% Buy | 72% Sell | ||
| Previous Opinion | 56% Buy | 8% Buy | 72% Sell | ||
| Last Month's Opinion | 80% Buy | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | -6.90% since 03/25/26 | +7.27% since 03/25/26 | ||
| Low | 46.34 on 03/26/20 | 19.72 on 03/27/26 | 23.30 on 03/27/26 | ||
| High | 48.02 on 03/31/20 | 23.20 on 03/26/26 | 29.09 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | +32.04% since 02/27/26 | -9.74% since 02/27/26 | ||
| Low | 40.30 on 03/18/20 | 15.52 on 03/06/26 | 22.42 on 03/24/26 | ||
| High | 48.02 on 03/31/20 | 23.85 on 03/25/26 | 31.00 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | +2.83% since 12/31/25 | -27.23% since 12/31/25 | ||
| Low | 40.30 on 03/18/20 | 15.52 on 03/06/26 | 22.42 on 03/24/26 | ||
| High | 48.02 on 03/31/20 | 24.68 on 01/26/26 | 37.70 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | +14.54% since 10/01/25 | -33.66% since 10/01/25 | ||
| Low | 22.25 on 10/08/19 | 15.08 on 11/04/25 | 22.42 on 03/24/26 | ||
| High | 48.02 on 03/31/20 | 25.32 on 10/08/25 | 47.65 on 11/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 2,284,582 | 2,232,189 | ||
| Shares Outstanding, K | 47,329 | 104,990 | 82,399 | ||
| Annual Sales | 3,000,000 | 2,198,240,000 | 0 | ||
| Annual Net Income | -102,690,000 | -713,410,000 | -154,650,000 | ||
| Last Quarter Sales | 3,000,000 | 442,930,000 | 0 | ||
| Last Quarter Net Income | -24,980,000 | -282,850,000 | -32,230,000 | ||
| 60-Month Beta | 1.04 | 0.42 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -3.58 on 02/25/26 | -0.40 on 03/12/26 | ||
| Latest Earnings Date | 05/14/20 | 05/05/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||